Galmed Pharmaceuticals Lt...
(GLMD)
undefined
undefined%
At close: undefined
3.43
0.00%
After-hours Jan 03, 2025, 03:52 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | n/a | n/a | n/a | 2.04M | 1.08M | 467.00K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 31.00K | 35.00K | 42.00K | 39.00K | 35.00K | n/a | n/a | n/a | 50.00K | n/a | n/a | n/a |
| Gross Profit | -31.00K | -35.00K | -42.00K | -39.00K | -35.00K | 2.04M | 1.08M | 467.00K | -50.00K | n/a | n/a | n/a |
| Operating Income | 7.49M | -17.65M | -32.88M | -30.21M | -22.38M | -10.71M | -12.36M | -16.88M | -10.88M | -9.14M | -14.57M | -3.14M |
| Interest Income | 375.00K | 297.00K | 562.00K | 1.19M | 1.92M | 959.00K | 65.00K | 35.00K | 253.00K | 40.00K | n/a | 6.00 |
| Pretax Income | -6.91M | -17.87M | -32.47M | -28.77M | -20.46M | -9.78M | -12.30M | -16.85M | -10.62M | -9.10M | -17.48M | -3.14M |
| Net Income | -6.91M | -18.57M | -31.95M | -27.61M | -18.54M | -9.86M | -12.30M | -16.95M | -10.62M | -9.10M | -17.48M | -3.15M |
| Selling & General & Admin | 3.92M | 4.66M | 5.66M | 4.13M | 4.20M | 4.44M | 3.80M | 3.08M | 3.25M | 2.48M | 7.36M | 694.00K |
| Research & Development | 3.57M | 12.99M | 27.22M | 26.08M | 18.18M | 8.31M | 9.65M | 14.27M | 7.63M | 6.66M | 7.21M | 2.44M |
| Other Expenses | -14.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.00K | n/a |
| Operating Expenses | -7.49M | 17.65M | 32.88M | 30.21M | 22.38M | 12.75M | 13.45M | 17.35M | 10.88M | 9.14M | 14.56M | 3.14M |
| Interest Expense | 11.00K | 215.00K | 43.00K | 31.00K | 33.00K | 42.00K | 49.00K | 67.00K | n/a | n/a | 34.00K | n/a |
| Selling & Marketing Expenses | 200.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | -7.49M | 17.65M | 32.88M | 30.21M | 22.38M | 12.75M | 13.45M | 17.35M | 10.88M | 9.14M | 14.56M | 3.14M |
| Income Tax | n/a | 705.00K | -519.00K | -1.16M | -1.92M | 75.00K | 12.36M | 106.00K | 21.24M | 1K | 1K | 6.00K |
| Shares Outstanding (Basic) | 230.00K | 1.68M | 1.64M | 1.42M | 1.41M | 1.21M | 832.49K | 758.31K | 740.03K | 688.25K | 711.66K | 337.96K |
| Shares Outstanding (Diluted) | 230.79K | 1.68M | 1.64M | 1.42M | 1.41M | 1.21M | 832.49K | 758.31K | 740.03K | 688.25K | 711.66K | 337.96K |
| EPS (Basic) | -30.05 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 | -14.77 | -22.36 | -14.35 | -13.23 | -24.57 | -9.32 |
| EPS (Diluted) | -29.95 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 | -14.77 | -22.36 | -14.35 | -13.23 | -24.57 | -9.32 |
| EBITDA | -6.87M | -17.62M | -32.84M | -30.17M | -22.34M | -10.33M | -12.13M | -16.71M | -10.82M | -9.13M | -14.57M | -3.13K |
| Depreciation & Amortization | 31.00K | 35.00K | 42.00K | 39.00K | 35.00K | 387.00K | 239.00K | 169.00K | 50.00K | 9.00K | 4.00K | 5.00K |